// App-Quantinova.ai

P2-05-17 : ARGX-111 depletes MET-expressing circulating tumor cells via enhanced ADCC, resulting in inhibition of metastasis

Researchers

Presenter

  • Morello V

Principal Investigators

  • Hultberg A

  • De Jonge N

  • Awada A

  • Michieli P

  • de Haard H

  • Huyghe L

  • Hanssens V

  • Brouckaert P

  • Saunders M

  • Dreier T

  • Thibault A

  • Rolfo C

  • Aftimos P

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Mammary carcinoma

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • ARGX-111

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved